Description
Job Description
· Minimum of 10 years of experience in Real-World Evidence (RWE), healthcare analytics, or a related field, with a proven track record of delivering analytical solutions for the pharmaceutical or healthcare industry.
· Strong hands-on experience in real-world data (RWD) sources, including medical claims, pharmacy claims, electronic health records (EHRs), chart review data, disease registries, healthcare surveys, clinical trial data, and other healthcare databases. Experience working with multiple data sources and integrating them for evidence generation is highly desirable.
· Minimum qualification of Master's in either Biostatistics/Data Science/Epidemiology/ Computer Science/Mathematics, or another relevant quantitative discipline.
· Good understanding of the pharmaceutical and healthcare ecosystem, including drug development, market access, medical affairs, epidemiology, or health economics and outcomes research (HEOR), is preferred.
· Excellent verbal and written communication skills, with demonstrated ability to interact effectively with clients and cross-functional stakeholders. Strong presentation, stakeholder management, project management, and interpersonal skills are essential.
· Proven ability to independently lead and execute multiple projects with minimal supervision while ensuring high-quality deliverables, adherence to timelines, and effective risk management.
· Strong analytical and problem-solving skills, with the ability to translate business questions into analytical approaches and communicate actionable insights.
· Demonstrated commitment to continuous learning, with the ability and willingness to adopt new methodologies, technologies, analytical tools, and industry best practices.
· Supporting mentoring junior team members, contributing to process improvements, and supporting business development initiatives will be an added advantage.
Any specific information that you would want us to gather from the candidates.
· Relevant Experience: At least 6 years of relevant experience within the overall professional experience in Real-World Evidence (RWE), healthcare analytics, epidemiology, biostatistics, or a related domain.
· Scientific Publications: Experience as an author or co-author of peer-reviewed publications, conference abstracts, posters, or presentations is highly desirable. Demonstrated contributions to scientific dissemination and evidence generation will be considered an advantage.
· Programming Skills: Strong hands-on programming expertise is required. Proficiency in SAS, R, Python, and SQL is essential, with the ability to write efficient, reproducible, and well-documented code for data extraction, transformation, analysis, and reporting.
· Technical Reporting & Client Communication: Demonstrated experience in preparing high-quality RWE technical reports, statistical analysis reports, study documentation, client presentations, and executive summaries. Ability to effectively communicate complex analytical findings to both technical and non-technical stakeholders is essential.
· Data Analysis & Visualization: Experience in analyzing large healthcare datasets and presenting insights using appropriate statistical methods, visualizations, and reporting tools is preferred.
· Quality & Compliance: Familiarity with industry’s best practices for documentation, quality control, reproducible research, and adherence to applicable regulatory and client standards is desirable.
Don't meet every job requirement? That's okay! Our company is dedicated to building a diverse, inclusive, and authentic workplace. If you're excited about this role, but your experience doesn't perfectly fit every qualification, we encourage you to apply anyway. You may be just the right person for this role or others.
Similar jobs
Est. 140,000 USD
Axsome Therapeutics is a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) conditions. We deliver scientific breakthroughs by identifying critical gaps in care and develop diffe…
Est. 209,500 USD
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress…
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress…
Est. 237,500 USD
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress…
Est. 165,000 USD
(ID: 2026-1572) Axle is a bioscience and information technology company that offers advancements in translational research, biomedical informatics, and data science applications to research centers and healthcare organiz…
Est. 80,000 USD
About Care Access Care Access is working to make the future of health better for all. With hundreds of research locations, mobile clinics, and clinicians across the globe, we bring world-class research and health service…
Est. 203,000 USD
About Us Kardigan is a heart health company working to make cardiovascular disease preventable, curable and no longer the leading cause of death in the world. It is Kardigan’s mission to develop multiple targeted treatme…
About Inizio Ignite Inizio Ignite is the global advisory partner for health and life sciences, encompassing connected expertise across Research Partnership, Putnam, Vynamic, and STEM. Guided by purpose, passion, and prec…
Est. 272,000 USD
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress…
Est. 261,000 USD
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress…
Est. 142,500 USD
Axsome Therapeutics is a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) conditions. We deliver scientific breakthroughs by identifying critical gaps in care and develop diffe…
Est. 169,500 USD
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress…
About Care Access Care Access is working to make the future of health better for all. With hundreds of research locations, mobile clinics, and clinicians across the globe, we bring world-class research and health service…
Est. 184,500 USD
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress…
Est. 274,500 USD
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress…
Est. 274,500 USD
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress…
Precision for Medicine is not your typical CRO. At Precision for Medicine we have brought together new technologies, expertise and operational scale to help the life sciences improve the speed, cost and success rate of b…
Precision for Medicine is not your typical CRO. At Precision for Medicine we have brought together new technologies, expertise and operational scale to help the life sciences improve the speed, cost and success rate of b…
Est. 209,500 USD
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress…
Est. 184,500 USD
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress…
Est. 209,500 USD
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress…
Est. 209,500 USD
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress…
Est. 237,500 USD
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress…
Est. 209,500 USD
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress…
Est. 209,500 USD
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress…
Est. 187,500 USD
“Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) a…
Est. 209,500 USD
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress…
Position Summary: The Senior Analyst II will be responsible for developing and maintaining Tableau dashboards and SQL programming to support clinical data management and analysis. This role requires a strong technical ba…
Est. 237,500 USD
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress…
We’re expanding our data engineering capabilities across Mexico, Brazil, Argentina, Colombia, Chile, and Peru, and we’re hiring a Senior Clinical Data Engineer to help build the foundation of this new regional function.…